Becton Dickinson & Co. (BDX) News
Filter BDX News Items
BDX News Results
|Loading, please wait...|
BDX News Highlights
- 500 - Internal server error
- Over the past 29 days, the trend for BDX's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- The most mentioned tickers in articles about BDX are CVE, CNA and HSIC.
Latest BDX News From Around the Web
Below are the latest news stories about Becton Dickinson & Co that investors may wish to consider to help them evaluate BDX as an investment opportunity.
In this article, we will take a look at some of the best healthcare stocks to buy based on the data of over 860 hedge funds tracked by Insider Monkey. You can skip our detailed analysis of the healthcare industry and go directly to see 5 Best Healthcare Stocks to Buy According to Hedge Funds. […]
Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.
Becton, Dickinson and Company BDX, popularly known as BD, recently partnered with USA Swimming the national governing body for the View post on CompanyNewsHQ : BDs (BDX) Rapid COVID-19 Test for US Olympic Trial Swimmers
Blood Testing Market Projected to be Resilient During 2030-Thermo Fisher Scientific, Inc., Roche Diagnostics, Becton Dickinson and Company, Cepheid
Blood Testing Market: Overview The growing prevalence of chronic diseases, infections, and disorders are urging many individuals to get tested for any ailments or health problems at an earlier stage. A large number of tests are available for detecting varied diseases
Single Cell Analysis Market With Leading Players like Agilent Technologies, Beckman Coulter, Becton Dickinson & Company (BD), Bio-Rad Laboratories, Fluidigm Corporation, GE Healthcare, Illumina, Merck KGaA Qiagen N.V., Thermo Fisher Scientific
An off-the-shelf report on Single Cell Analysis Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such
BD (BDX) to provide rapid antigen testing for COVID-19 at the U.S. Olympic Team Trials and other competitive swimming events on behalf of USA Swimming.
Becton, Dickinson and Company with ticker code (BDX) have now 15 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 300 and 260 calculating the average target price we see 278.4. With the stocks previous close at 245.41 this is indicating there is a potential upside of 13.4%. The 50 day moving average now sits at 244.67 and the 200 day MA is 247.79. The market cap for the company is $70,564m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="BDX" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products wo...
No summary available.
USA Swimming Partners with BD to Provide COVID-19 Screening for the Olympic Trials and Other Competitive Swimming Events
USA Swimming, the national governing body for the sport of swimming in the United States, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide COVID-19 testing at USA Swimming events.
BD (BDX) receives 2 billion pandemic orders for needles and syringes to support global COVID-19 vaccination efforts.